These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21850367)

  • 1. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
    Tozawa K; Sagawa M; Kizaki M
    Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    PLoS One; 2014; 9(4):e95846. PubMed ID: 24755677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
    Sha M; Ye J; Zhang LX; Luan ZY; Chen YB; Huang JX
    Pharmacology; 2014; 93(1-2):39-46. PubMed ID: 24434352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
    Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
    Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
    Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
    Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotrimazole inhibits growth of multiple myeloma cells in vitro via G0/G1 arrest and mitochondrial apoptosis.
    Song Y; Zhang H; Geng J; Chen H; Bo Y; Lu X
    Sci Rep; 2024 Jul; 14(1):15406. PubMed ID: 38965397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
    Yu X; Meng X; Xu M; Zhang X; Zhang Y; Ding G; Huang S; Zhang A; Jia Z
    EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells.
    Wu D; Zhang W; Chen Y; Ma H; Wang M
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1194-1200. PubMed ID: 31347196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
    Yang M; Huang J; Pan HZ; Jin J
    Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
    Wang Y; Zhang XL; Sun CM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
    Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P
    Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity.
    Zhong YL; Xu GJ; Huang S; Zhao L; Zeng Y; Xiao XF; An JL; Liu J; Yang T
    Eur J Pharmacol; 2019 Jun; 853():184-192. PubMed ID: 30928629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway.
    Yang L; Chen J; Han X; Zhang E; Huang X; Guo X; Chen Q; Wu W; Zheng G; He D; Zhao Y; Yang Y; He J; Cai Z
    Protein Cell; 2018 Sep; 9(9):770-784. PubMed ID: 29441489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of celastrol on enhancing apoptosis of ovarian cancer cells via the downregulation of microRNA‑21 and the suppression of the PI3K/Akt‑NF‑κB signaling pathway in an in vitro model of ovarian carcinoma.
    Zhang H; Li J; Li G; Wang S
    Mol Med Rep; 2016 Dec; 14(6):5363-5368. PubMed ID: 27840916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma.
    He D; Xu Q; Yan M; Zhang P; Zhou X; Zhang Z; Duan W; Zhong L; Ye D; Chen W
    BMC Cancer; 2009 Sep; 9():343. PubMed ID: 19778460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
    Du HF; Yu LJ; Meng YF; Lv HY; Meng J; Song XN; Zhang JQ
    Leuk Lymphoma; 2013 Mar; 54(3):607-18. PubMed ID: 22889356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.